Ramucirumab
Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors. Ramucirumab is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding of VEGFR ligands: VEGF-A, VEGF-C, and VEGF-D.
Online Inquiry
| CAT# | R1651 |
| CAS | 947687-13-0 |
| M.F/Formula | C₂₈₅H₄₃₄N₇₄O₈₈S₂ |
| M.W/Mr. | 6369.07 |
Write a review
Ask a question
My Review for Ramucirumab
Required fields are marked with *
×
Ask a Question for Ramucirumab
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
